Advertisement

Topics

Advanced Photonix, Inc. Company Profile

20:27 EDT 22nd September 2017 | BioPortfolio

Advanced Photonix, Inc. (R) (NYSE Amex: API) is a leading supplier with a broad offering of optoelectronic products to a global customer base. We provide optoelectronic solutions, high-speed optical receivers and terahertz instrumentation for telecom, homeland security, military, medical and industrial markets. With our patented technology and state-of-the-art manufacturing we offer industry leading performance, exceptional quality, and high value added products to our OEM customer base. For more information visit us on the web at www.advancedphotonix.com.


News Articles [513 Associated News Articles listed on BioPortfolio]

Unexpired Nitroglycerin Injection in 5 Percent Dextrose USP by Advanced Pharma in Houston: Recall - Sub Potency

[Posted 06/15/2017] AUDIENCE: Pharmacy, Cardiology, Nursing ISSUE: Advanced Pharma, Inc. d/b/a Avella of Houston (“Advanced Pharma”) is voluntarily recalling all unexpired lots of Nitrogly...

Advanced Pharma recalls certain unexpired NitroGlycerin injection in 5% products

Advanced Pharma, Inc. d/b/a Avella of Houston (Advanced Pharma) is voluntarily recalling all unexpired lots of NitroGlycerin products that were produced at Advanced Pharma's Houston location between M...

81% of hopitals have basic EHR programs; advanced utilization lags

The implementation of electron

Brief psychological intervention reduces depressive symptoms in patients with advanced cancer

Advanced cancer triggers enormous distress and brings challenges that can seem overwhelming. Yet, most cancer centers lack systematic approaches to help patients and families manage the practical and ...

81% of hospitals have basic EHR programs; advanced utilization lags

The implementation of electron

Lilly Receives Priority Review for Advanced Breast Cancer Therapy

NewsFDA grants priority review for Lilly's abemaciclib for the treatment of advanced breast cancer. Advanced breast cancer includes metastatic breast cancer that has spread to other parts of the body...

Psychological intervention relieves distress in patients with advanced cancer

Advanced cancer triggers enormous distress and brings challenges that can seem overwhelming. Yet, most cancer centers lack systematic approaches to help patients and families manage the practical and ...

ASCO 2017: Psychological intervention relieves distress in patients with advanced cancer

Advanced cancer triggers enormous distress and brings challenges that can seem overwhelming.  Yet, most cancer centres lack systematic approaches to help patients and families manage the practical a...

PubMed Articles [1097 Associated PubMed Articles listed on BioPortfolio]

Exploring the development and identity of advanced practice nursing in the UK.

The development of advanced nurse practice in the UK has been slow compared to some parts of the world. This article explores the history of advanced level nursing, the drivers for advanced nurse prac...

How does role transition affect the experience of trainee Advanced Clinical Practitioners: Qualitative evidence synthesis.

Advanced Clinical Practitioners have been developed to address current and future gaps in the medical workforce. Insight into problems associated with Advanced Clinical Practitioner transition may hel...

Can the Sum of Adenoma Diameters (Adenoma Bulk) on Index Examination Predict Risk of Metachronous Advanced Neoplasia?

Recent data suggest that adenoma size and number are more important predictors of metachronous colorectal neoplasia than advanced histology. Furthermore, there is poor reproducibility in diagnosing ad...

Health-Related Quality of Life After the Diagnosis of Locally Advanced or Advanced Prostate Cancer: A Longitudinal Study.

Approximately 20% of men with a diagnosis of prostate cancer present with locally advanced or advanced disease. Few studies consider longer-term impact of disease progression and treatment adverse eff...

Dynamic evaluation of circulating tumour cells in patients with advanced gastric and oesogastric junction adenocarcinoma: Prognostic value and early assessment of therapeutic effects.

The identification of dynamic biomarkers in advanced gastric and oesogastric junction adenocarcinoma (GOA) could help to tailor strategies for each patient. Enumeration of circulating tumour cells (CT...

Clinical Trials [3878 Associated Clinical Trials listed on BioPortfolio]

Study of TAK-733 in Adult Patients With Advanced Nonhematologic Malignancies

The purpose of this study is to evaluate the safety, pharmacokinetics, pharmacodynamics and maximum tolerated dose of TAK-733 in patients with advanced, nonhematologic tumors. The expansi...

Pharmacological Study of Intravenous OTS167 in Patients With Refractory or Relapsed Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Advanced Myelodysplastic Syndromes, Advanced Myeloproliferative Neoplastic Disorders, or Advanced Chronic Myelogenous

The purpose of Phase I of this study is to test the safety and tolerability of the investigational drug, OTS167, and that of Phase II of this study is to confirm the potential response ben...

Phase 1 Study of MKC-1 in Patients With Advanced Cancer

This is an open-label study to determine the highest dose of MKC-1 that may be administered daily on a continuous basis for patients with advanced or refractory solid tumors.

PH 1 Biomarker Study of Nivolumab and Ipilimumab and Nivolumab in Combination With Ipilimumab in Advanced Melanoma

The purpose of this study is to evaluate pharmacodynamic changes of Nivolumab and Nivolumab in combination with Ipilimumab treatment on the biomarkers measured in the peripheral blood and ...

Evaluation of the Efficacy of Long-acting Release Octreotide in Patients With Advanced Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is one of the most common malignant disease worldwide with an increasing incidence in industrialized countries. For patients with advanced HCC no efficient t...

Companies [723 Associated Companies listed on BioPortfolio]

Advanced Photonix, Inc.

Advanced Photonix, Inc. (R) (NYSE Amex: API) is a leading supplier with a broad offering of optoelectronic products to a global customer base. We provide optoelectronic solutions, high-speed optical r...

Advanced BioHealing, Inc. (ABH)

Advanced BioHealing develops and commercializes living cell therapies that repair damaged human tissue and enable the body to heal itself. A privately held company, Advance...

Advanced Scientifics

Founded in 1985, Advanced Scientifics, is one of the leaders in the design and manufacture of disposable medical devices, bag systems and tubing assemblies for the pharmaceutical, biotechnology and me...

Advanced Bionics, LLC

Advanced Bionics is a global leader in developing the most advanced cochlear implant systems in the world. Founded in 1993 and a subsidiary of the Sonova Group since 2009, AB deve...

Advanced Digital Eyewear Inc.

Advanced Digital Eyewear (www.My2020EyesDirect.com) offers hundreds of select frames from up-and-coming and well-known designers and advanced-technology lenses in a simple persona...

More Information about "Advanced Photonix, Inc." on BioPortfolio

We have published hundreds of Advanced Photonix, Inc. news stories on BioPortfolio along with dozens of Advanced Photonix, Inc. Clinical Trials and PubMed Articles about Advanced Photonix, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Advanced Photonix, Inc. Companies in our database. You can also find out about relevant Advanced Photonix, Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record